Medtech Insight: 世界の医療機器・医療技術の最新情報
QUOTED. 4 March 2021. Meghan Scanlon.
04 Mar 2021
Boston Scientific has agreed to pay $1.07bn to acquire Lumenis’ surgical laser business from Baring Private Equity Asia. See what...
There may have been a significant increase in the amount of regulatory activity at EU level of late, but the medtech industry remains alarmed at the lack of readiness of the system, and calls for an urgent focus on IVDs now too.
Devoting the same level of attention and energy to the IVD Regulation as to the Medical Device Regulation is long overdue. That is the view of the EU’s largest medtech industry association, MedTech Europe, in a statement put out to mark the half-way point of the EU IVD Regulation’s five-year transition period and the six-month countdown to the MDR.
MedTech Europe notes that the IVDR will bring an estimated eight-fold workload increase to IVD notified bodies.
“It is clear that the EU needs to start urgently and proactively addressing this situation if patients and healthcare systems are to retain access to diagnostic tests,” it says.
The association says it is “alarmed” that only about ten organizations have applied so far to be notified bodies under the IVDR, with just two and a half years until the date of full application of the IVDR, on 26 May 2022.
Of the ten, only BSI UK and DEKRA have been designated so far, Medtech Insight notes.
Delays, Errors And Confusion
Despite the designation of seven notified bodies under the MDR and the two under the IVDR), the recent barrage of guidance documents, MedTech Europe is in no doubt that the tools needed for implementation are coming too slowly and too late.
Medtech Insight, meanwhile, also notes that the recent rapid proliferation of decisions and documents intended to support MDR and IVDR implementation is starting to result in multiple situations littered with ambiguity, and even errors, which will make compliance difficult, if not impossible. One instance of this is the EU software guidance document; another is the huge challenges being brought about by factoring in and indeed understanding the delay in the introduction of Eudamed 3, the updated version of the EU’s medical device database.
“We remain seriously held back by the slow and piecemeal implementation of the new regulatory framework,” the MedTech Europe says.
The incomplete implementation by EU member states and European Commission of the MDR and the IVDR threatens the continuity of patient access and care, both in Europe and beyond, the association says. It argues that this will impact not just the EU, but “more than 100 countries around the world that rely on the EU CE marking of medical technologies.”
Medtech Insight: 世界の医療機器・医療技術の最新情報
04 Mar 2021
Boston Scientific has agreed to pay $1.07bn to acquire Lumenis’ surgical laser business from Baring Private Equity Asia. See what...
Medtech Insight: 世界の医療機器・医療技術の最新情報
03 Mar 2021
Medtech Insight spoke to attorney Greg Dadika about mass tort litigation, including industry trends, how to find the right law...
Medtech Insight: 世界の医療機器・医療技術の最新情報
03 Mar 2021
Health technology assessment body NICE has now recommended that selective internal radiation therapy can be used on England’s National Health...
専任スタッフによるデモンストレーションを兼ねたサービスの詳しいご説明、または無料トライアルを常時受け付けています。ご希望の場合は下記のフォームよりお気軽にお申し込みください。
*一部のサービスでは無料トライアルをご利用になれません。
新型コロナウイルス感染拡大防止のため在宅勤務を実施しています。お問合せの際は下記メールアドレスまたは各営業スタッフまでご連絡下さいますようご協力をお願い申し上げます。
インフォーマインテリジェンス合同会社
ファーマインテリジェンス
inquiry.jp@informa.com
*Omdia(ICT産業の情報)に関するお問い合わせはこちら
Contact_OmdiaJapan@omdia.com
オンラインショップのレポートストアでは、医療用医薬品の市場調査・分析レポートを常時1000本以上販売しています。レポート1本単位で購入でき、オンラインでご提供いたします。
お探しの情報が見つからない場合はお問い合わせ先までお気軽にご連絡ください。